** Shares of Biome Australia BIO.AX rise as much as 7.3%
to a record high of A$0.22
** Microbiome healthcare firm reports unaudited half-yearly
sales revenue of A$6 mln ($4.09 mln), up 77.7% y/y, and Q2
unaudited sales revenue of A$3.3 mln, up 83.3%
** "Strong start to the financial year points toward the
likelihood of continued growth through the second half of FY24"-
Managing Director
** Nearly 512,500 shares change hands, compared with the
30-day average volume of about 322,200 shares
** Stock nearly tripled in value last year
($1 = 1.4684 Australian dollars)
(Reporting by Megha Rani in Bengaluru)
((Megha.Rani2@thomsonreuters.com;))